Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Synthesis, Spectroscopic, Computational, and PDT Investigations of a Series of Cationic Meso-(3-pyridyl)-indolylstyryl-BODIPYs.

Created on 12 Nov 2026

Authors

Caroline S Gwaro, Prajesh Shrestha, Seetharama D Jois, Venkatesh Mayandi, Petia Bobadova-Parvanova, Jack F Lamm, Alexander C Sweetman, Sydney Nelms, Xin Gu, Frank R Fronczek, Kevin M Smith, Maria da Graça H Vicente

Published in

Journal of medicinal chemistry. Volume 69. Issue 21. Pages 25641-25655. Nov 12, 2026.

Abstract

Boron dipyrromethene (BODIPY) dyes bearing a meso-(3-pyridyl) moiety have found multiple applications, such as pH and metal ion sensors, fluorescence probes, and as sensitizers for phototherapy. A series of 3-mono- and 3,5-di-indolylstyryl-BODIPYs bearing a meso-(3-pyridyl) group and different 2,6-substituents (H, Cl, Br, I) was synthesized and their properties investigated. The extension of π-conjugation via the indolylstyryl groups produced bathochromic shifts in the absorption and emission spectra of up to 200 nm, while the introduction of the heavy 2,6-iodo groups induced the highest in vitro and in vivo phototoxicity. In a comparison study with Photofrin, mono-indolylstyryl-BODIPY 4a cat was found to be a potent photosensitizer (IC50 = 11 μM at 3 J/cm2; under the same conditions Photofrin's IC50 = 24 μM) in HT-29 cells. In mice bearing HT-29 xenograft tumors, BODIPY 4a cat shows similar PDT efficacy as Photofrin and is the most promising photosensitizer among the new series of meso-(3-pyridyl)-BODIPYs.

PMID:
43018608
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement